We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-0.86%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.19B
AUM Growth
-$288M
Cap. Flow
-$155M
Cap. Flow %
-13.04%
Top 10 Hldgs %
42.35%
Holding
170
New
36
Increased
27
Reduced
26
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$49M
2
LLY icon
Eli Lilly
LLY
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$26.3M
4
PANW icon
Palo Alto Networks
PANW
+$13.1M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$60.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.4M
3
GNRC icon
Generac Holdings
GNRC
+$14.3M
4
LPSN icon
LivePerson
LPSN
+$14.2M
5
AMZN icon
Amazon
AMZN
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 63.14%
2 Technology 10.82%
3 Industrials 3.99%
4 Financials 3.13%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.42T
$11.7M 0.98%
34,400
+7,400
+27% +$2.67M
CRNX icon
27
Crinetics Pharmaceuticals
CRNX
$8.84B
$11.5M 0.97%
548,643
-85,445
-13% -$1.79M
BMRN icon
28
BioMarin Pharmaceuticals
BMRN
$11.6B
$11.5M 0.97%
+149,017
New +$11.8M
TWLO icon
29
Twilio
TWLO
$30B
$11.3M 0.95%
35,500
+9,000
+34% +$3.28M
ALT icon
30
CALL
Altimmune
ALT
$552M
$11.3M 0.95%
+1,000,000
New +$12.2M
NICE icon
31
Nice
NICE
$5.79B
$10.7M 0.9%
37,786
-39,000
-51% -$10.8M
VINC
32
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$10.6M 0.89%
32,729
+21,356
+188% +$6.23M
VTGN icon
33
VistaGen Therapeutics
VTGN
$9.89M
$10.5M 0.88%
127,498
-8,524
-6% -$741K
KRNT icon
34
Kornit Digital
KRNT
$705M
$10.4M 0.88%
72,076
-75,717
-51% -$9.99M
IMTX icon
35
Immatics
IMTX
$1.18B
$10.4M 0.87%
+800,043
New +$10.2M
INBX
36
DELISTED
Inhibrx, Inc. Common Stock
INBX
$10.3M 0.87%
310,077
+120,994
+64% +$3.68M
AUDC icon
37
AudioCodes
AUDC
$244M
$10.3M 0.87%
316,428
-68,766
-18% -$2.23M
TEVA icon
38
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$10.2M 0.86%
1,050,000
-860,000
-45% -$8.05M
ARYD
39
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$10.1M 0.85%
1,000,000
+500,000
+100% +$5.05M
OMGA
40
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$9.95M 0.84%
+527,948
New +$10.1M
ALXO icon
41
ALX Oncology
ALXO
$261M
$9.51M 0.8%
128,706
-64,022
-33% -$4.27M
NKE icon
42
Nike
NKE
$61.9B
$9.44M 0.79%
+65,000
New +$10.6M
LENZ
43
LENZ Therapeutics
LENZ
$166M
$8.71M 0.73%
75,896
+72,331
+2,029% +$10.7M
RUN icon
44
Sunrun
RUN
$2.34B
$8.32M 0.7%
189,000
+117,000
+163% +$5.58M
ONCR
45
DELISTED
Oncorus, Inc.
ONCR
$8.23M 0.69%
880,702
-12,846
-1% -$147K
TEVA icon
46
Teva Pharmaceuticals
TEVA
$40.8B
$8.11M 0.68%
832,878
– –
CSTE icon
47
Caesarstone
CSTE
$72.3M
$8M 0.67%
644,146
– –
ISEE
48
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.88M 0.66%
485,001
-14,999
-3% -$163K
ADSK icon
49
Autodesk
ADSK
$49.5B
$7.84M 0.66%
+27,500
New +$8.42M
IDYA icon
50
IDEAYA Biosciences
IDYA
$3.42B
$7.51M 0.63%
294,619
-40,175
-12% -$938K
1
2
3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sphera Funds Management held 170 positions worth $1.19B, down 19% from $1.48B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $155M in Q3 2021, closing 54 positions and reducing 26 holdings. Its most notable exit was Merck, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 55% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Pfizer worth $47.6M.

  • Sphera Funds Management's largest Q3 2021 buy was Pfizer: 1,106,528 shares worth $47.6M.
  • Sphera Funds Management added most to Eli Lilly in Q3 2021, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $28.4M.
  • Sphera Funds Management fully exited Merck in Q3 2021, selling an estimated $60.1M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $1.19B portfolio in Q3 2021.
  • Sphera Funds Management opened 36 new positions and closed 54 in Q3 2021.
  • Sphera Funds Management's portfolio value fell 19% quarter-over-quarter to $1.19B.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.